Stella Xu

Insider Reports History

Location
Redwood City, CA
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stella Xu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Design Therapeutics, Inc. Director Stock Option (right to buy) 15,000 31 May 2023 Direct
NextCure, Inc. Director Stock Option (Right to Buy) 14,250 24 Jun 2021 Direct
Tempest Therapeutics, Inc. Director Stock Option (Right to Buy) 6,635 01 Jul 2021 Direct

Insider Reports Filed by Stella Xu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DSGN Design Therapeutics, Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 16:31
DSGN Design Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 17:17
DSGN Design Therapeutics, Inc. 18 Mar 2022 4 -$11,266,197 4 Director 22 Mar 2022, 19:26
TPST Tempest Therapeutics, Inc. 01 Jul 2021 1 $0 4/A Director 20 Sep 2021, 20:10
TPST Millendo Therapeutics, Inc. 25 Jun 2021 1 $0 4 Director 29 Jun 2021, 21:56
TPST Millendo Therapeutics, Inc. 25 Jun 2021 0 $0 3 Director 29 Jun 2021, 21:44
NXTC NextCure, Inc. 24 Jun 2021 1 $0 4 Director 28 Jun 2021, 18:16